# A Research Study of a New Medicine NNC0113-6856 in Healthy Males

> **NCT05521256** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 70 (actual)

## Conditions studied

- Healthy Volunteers
- Type 2 Diabetes

## Interventions

- **DRUG:** NNC0113-6856
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05521256
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-26
- **Primary completion:** 2023-03-27
- **Final completion:** 2023-03-27
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05521256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05521256, "A Research Study of a New Medicine NNC0113-6856 in Healthy Males". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05521256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*